High impact clinical trials yield results that could lead to improved kidney care

Posted: November 16, 2014 at 1:47 am

PUBLIC RELEASE DATE:

15-Nov-2014

Contact: Kurtis Pivert kpivert@asn-online.org 202-699-0238 American Society of Nephrology @ASNKidney

Philadelphia, PA (November 15, 2014) -- The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, November 11-16 at the Pennsylvania Convention Center in Philadelphia, PA.

ACT-AKI: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects

ADVANCE-ON: long term benefits of intensive glucose control for end-stage kidney disease

HALT Progression of Polycystic Kidney Disease (HALT PKD) Trials: Primary Results of a 2x2 Factorial Trial in Early Stage CKD HALT Progression of Polycystic Kidney Disease Trials: Primary results of a randomized trial in moderately advanced stage CKD

Impact of Extended Weekly Hemodialysis Hours on Quality of Life and Clinical Outcomes: the ACTIVE Dialysis Multinational Trial

Randomized Clinical Trial of Ergocalciferol Supplementation in 25 Vitamin D Deficient Hemodialysis Patients

Renal Efficacy and Safety of Anti-TGF-1 Therapy in Patients with Diabetic Nephropathy

See the rest here:
High impact clinical trials yield results that could lead to improved kidney care

Related Posts

Comments are closed.

Archives